Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Evaluation of the XIENCE Everolimus Eluting Coronary Stent System in the Treatment of Women With de Novo Coronary Artery Lesions

NCT01182428 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT01182428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01182428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Evaluation of the XIENCE Everolimus Eluting Coronary Stent System in the Treatment of Women With de Novo Coronary Artery Lesions
Lead sponsor
Abbott Medical Devices
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2008
Completion date
July 31, 2011
Enrollment
455 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

coronary arteriosclerosis, coronary artery disease, coronary artery restenosis, coronary artery stenosis, myocardial ischemia, stent thrombosis, total coronary occlusion, vascular disease